The objective of the present study was to find out the predictors of relapse. One hundred fifty children with a first episode of idiopathic nephrotic syndrome were followed for 12 months after initial treatment. Sixty-one (40.7%) children had no relapse, and 89 (59.3%) had relapses. A significantly higher proportion of children with disease onset between 1 and 3 years were relapsers in comparison with those with disease onset at 4-6 (p < 0.03) and 7-13 (p < 0.001) years. Risk of relapse was 2.99 times higher in this 1-3 year age-group as compared with patients aged >6 years (p ¼ 0.001). Children responding between 1 and 2 weeks after start of treatment had a 0.423 times lesser risk of relapse than those who responded after 4 weeks (p ¼ 0.023). Relapsers had significantly higher incidence of infection at relapse than at other time points (p < 0.001). Onset of disease in younger age and delayed response to prednisolone therapy were found as significant predictors for relapse.
Introduction
The incidence of nephrotic syndrome is 2-7 cases per 100 000 <16-year-old children per year [1] . In Asia, a higher incidence of 9-16 cases per 100 000 children per year has been found [2] . Approximately 90% of the nephrotic syndromes in children are idiopathic and steroid sensitive, with a favorable prognosis [3] , while the remaining 10% do not respond and are defined as steroid resistant. Abnormal T-cell functions leading to release of certain cytokines and lymphokines, which cause altered glomerular basement permeability and hence proteinuria, may be involved in the pathogenesis of nephrotic syndrome and its relapses [4] . One-third of patients do not experience any relapse after first remission [5] . However, $70% of the steroid-sensitive patients suffer a relapsing course, and some become steroid dependant [6] . Patients with frequent relapses and steroid dependency are at risk for steroid toxicity because of the need of repeated courses of prednisolone to achieve remission.
It is often difficult to predict the course of disease after treatment of the first episode. The International Study of Kidney Disease in Children [7] has analyzed the factors at presentation that can be correlated with future outcome and reported that the number of relapses occurring during the first 6 months were highly predictive of future relapses. Constantinescu et al. [1] reported that age, gender, race and hematuria, as independent variables, do not predict relapses in the +first year. However, they found that the patients without hematuria and who achieved remission within the first week of therapy were more likely to be infrequent relapsers. Noer [8] reported that the time interval between steroid response and the first relapse, the number of relapses within the first 6 months and infection during the first relapse were significant predictors of relapse in his study subjects.
Further in the recent past, it has been shown that duration of therapy of first episode also matters. When the treatment was prolonged beyond 8 weeks [6] or 12 weeks [9, 10] , there was a significant decrease in frequency of relapses in the next 12-24 months.
However, most studies were neither blinded nor adequately powered. Parents are mainly concerned about the future course of disease, especially in developing countries, where relapses are often precipitated by high incidence of infections and they not only create anxiety but also pose a financial burden for the families. As such, there is no consistency in reports that can reliably guide pediatric nephrologists regarding the prediction of relapses. We analyzed the largest patient cohort reported to date with the objectives to identify predictors of relapse and their predictive ability in patients with steroid-sensitive nephrotic syndrome.
Materials and Methods
This was a retrospective study conducted on patients with a first episode of idiopathic nephrotic syndrome, aged 1-13 years, with generalized edema, hypoalbuminemia (serum albumin, <2.5 mg/dl), heavy proteinuria (>40 mg/m 2 /h) and hypercholesterolemia (serum cholesterol >200 mg/dl), presenting to the Pediatric Nephrology Clinic of the Department of Pediatrics of the Banaras Hindu University, Varanasi, India, between February 2004 and January 2010. Children who had received previous immunosuppressive treatment or who had systemic diseases known to cause nephrotic syndrome were excluded. Patients who did not complete treatment or achieved remission by 8 weeks of prednisolone treatment, who had follow-up period of <12 months after remission, who had contraindications to steroid therapy or whose parents did not give consent, were also excluded. One hundred fifty children fulfilled all the criteria and were included in the study. The informed consent was obtained from the parents or authorized representative of patients. The protocol of the study was approved by the Institute Ethical Committee.
Follow -up
The first episode was treated with prednisolone (2 mg/ kg/day in 2-3 divided doses for 6 weeks, followed by 1.5 mg/kg in a single morning dose given on alternate days for 6 weeks) [11] . The response to treatment was assessed by clinical examination and detection of proteinuria by heat precipitation method or 24-h proteinuria. All patients were followed at least every 2 months for 12 months after completion of the treatment of the first episode. Search for infection was done at every visit in both relapsers and non-relapsers. The data regarding pattern of relapses and precipitating factors like infections were recorded during follow-up. A renal biopsy was not performed in any patient, as they were steroid responsive. Patients were categorized during follow-up into the following groups, depending on their response to therapy:
Remission: proteinuria of <4 mg/m2/h or urine albumin nil or traces for 3 consecutive days.
Relapse: proteinuria of >40 mg/m 2 /h or urine albumin 3þ or more by heat precipitation test for 3 consecutive days, having previously been in remission. Infrequent relapser nephrotic syndrome: patients having less than two relapses within 6 months or less than four relapses within 12 months of response. Frequent relapser nephrotic syndrome: patients having two or more relapses within 6 months or four or more relapses within 12 months of response. Steroid-dependent nephrotic syndrome: the patients having two consecutive relapses when receiving prednisolone on alternate days or within 14 days of its discontinuation.
Infrequent relapses were treated with prednisone, 2 mg/kg/day, until remission, followed by 1.5 mg/kg on alternate days for 4 weeks. In patients with frequent relapser nephrotic syndrome/steroid-dependent nephrotic syndrome, prednisolone was tapered gradually over 12-18 months to a minimum of 0.25-0.5 mg/kg after achieving remission with 2 mg/ kg/day. The proportion of patients with sustained remission, infrequent relapses, frequent relapses and steroid dependency; the cumulative dose of prednisone received for treatment of first episode; and subsequent relapses during 12 months of follow-up were recorded. Both relapsers and non-relapsers having clinical features of infections were thoroughly investigated and treated appropriately. Respiratory tract infections were noted based on symptoms such as fever, cough and respiratory distress and auscultatory and X-ray chest findings. Presence of vomiting, loose stools, presence or absence of features of dehydration and positive stool microscopy indicated gastrointestinal infection. Children presenting with abdominal pain, tenderness and rigidity of abdominal wall and positive abnormal peritoneal fluid biochemistry results were diagnosed as having peritonitis. The diagnosis of urinary tract infection was based on the urinary symptoms, positive pus cells and positive culture results of urine samples (growth of single organism of >10 5 cfu/ml in a mid-stream urine sample).
Statistical analysis
The data were analyzed using SPSS version 16.0 software. Student's t-test was applied for comparison between groups showing normal distribution, and Mann-Whitney U-test was used for parameters having non-Gaussian distribution. Chi-square and Fisher's exact tests were used to compare the data of proportions. Cox proportion hazard model was applied to find out the risk of relapse. Canonical discriminant function analysis was used to find out the scores for the factors found significantly predicting the relapses (age-group and time to response).
Results
There were 108 male and 42 female patients, ratio being 2.6:1. Children were divided into three agegroups: 1-3 years (n ¼ 63), 4-6 years (n ¼ 48) and 7-13 years (n ¼ 39). One hundred cases (66.7%) came from rural area, and 100 children (78%) had normal nutritional status based on their body mass index, calculated after subsidence of edema. Hypertension (blood pressure >95th percentile for height, age and gender on three or more occasions), hematuria (!5 red blood cells/high-power field), anemia (hemoglobin <11 g/dl in 1-6-year-old and <12 g/dl in 7-13-year-old patients) and azotemia (rise of serum creatinine level of >50% from the baseline with regard to age and gender; upper limit of normal, 0.9 mg/dl in male and 0.7 mg/dl in female patients AE0.2 mg/dl for each) were present in 44 (29.3%), 24 (16%), 16 (10.7%) and 7 (4.7%) children, respectively.
The patient characteristics at the initial presentation are presented in Table 1 . The parameters such as gender, residence, body mass index, hematuria, hypertension, anemia, presence of infection, azotemia, serum albumin and cholesterol did not differ significantly among different age-groups.
Sixty-five (43.3%) children responded between 1 and 2 weeks, 62 (41.3%) between 3 and 4 weeks and 23 (15.3%) between 5 and 8 weeks of prednisolone treatment. Time to response did not differ significantly among different age-groups. Sixty-one Baseline characteristics of study subjects are presented. The parameters did not differ significantly among the three agegroups. n, number of cases.
(40.7%) children had no relapse, whereas 89 (59.3%) patients had relapses; of these, 78 (52% of all patients) were infrequent relapsers, 10 (6.7 %) were frequent relapsers, and 1 (0.6%) was steroid dependent.
In the further analysis, infrequent relapsers, frequent relapsers and the steroid-dependent patients were grouped together. It was observed that a significantly higher proportion of children aged 1-3 years (n ¼ 47) had relapses in comparison with children aged 4-6 (n ¼ 26, p < 0.03) or 7-13 (n ¼ 16, p < 0.001) years (Fig. 1) . The median number of relapses during the first 6 months of follow-up in the 1-3-year age-group (0.73 AE 0.72) was significantly higher than in the 4-6-(0.42 AE 0.65, p < 0.01) and 7-13-year (0.26 AE 0.44, p < 0.001) age-groups. However, it did not differ significantly among different age-groups during the following 6 months of follow-up. The Cox proportion hazard model was applied to find out the hazard rate of relapse, and it was found that patients with a disease onset between 1 and 3 years had a 2.99 times higher risk of relapse than those aged >6 years (p ¼ 0.001). Children responding between 1 and 2 weeks after start of treatment had a significant lower risk of relapse compared with those responding after >4 weeks of treatment (hazard rate: 0.423, p < 0.023; Table 2 ).
The descriptive parameters affecting the relapse are shown in Table 3 . It was observed that infection was the only parameter that was significantly associated with first relapse (p < 0.001). The infections present in relapsers included respiratory tract infection in 50 (56.1%), urinary tract infection in 8 (9.0%) and gastrointestinal tract infection in 4 (4.5%) cases, and one child non-relapsers had urinary tract infection.
Because the children may have the infections even in non-relapse period, the data were further analyzed. It was found that the mean number of infections was significantly more in relapsers (3.12 AE 1.39) than in non-relapsers (2.08 AE 0.95, p < 0.001). During 12 months of follow-up, the incidence of infection in relapsers at relapse was 74.8% (95 in 127 episodes of relapse), whereas it was only 15.5% (183 in 1180) at other time points (p < 0.001). Among nonrelapsers, the incidence of infection was 20.1% (127/ 627) at other time points and very close to infection rate among relapsers at other time points.
The quantitative variables affecting the relapse were also analyzed. The children with relapses had significantly lower median age of disease onset (36 vs. 72 months, p ¼ 0.002), took longer median time to response (4 vs. 2 weeks, p ¼ 0.011) and had received higher mean cumulative dose of steroid (2838 AE 1087 mg vs. 2204 AE 773 mg, p < 0.001) than non-relapsers. In relapsers, the median period between steroid response and first relapse was 22 weeks. Children having no relapse in first 6 months did not relapse in subsequent 6 months also.
Of the various factors analyzed, age at presentation and time to response were found to be significant predictors of relapse. The canonical discriminant function analysis was applied to find out the discriminant function score for each parameter to categorize the patients into relapser and non-relapser groups. The scores assigned for age-group were as follows: 1 for 1-3 years, 2 for 4-6 years and 3 for 7-13 years. The scores assigned for time to response were as follows: 1 for 1-2 weeks, 2 for 3-4 weeks and 3 for 5-8 weeks. The equation for relapser was À6.559 þ 2.817 age group score þ 3.842 times time to response score, and the equation for non-relapser was À6.965 þ 3.558 age-group score þ 3.256 time to response score. The categorization of children as relapser or non-relapser was determined by substituting score values of predictors in both equations. The equation yielding higher value would define the category of the case.
Discussion
The basic characteristics like gender, place of residence, body mass index, nutritional status, presence or absence of hematuria, hypertension, anemia, infections, azotemia, serum albumin and cholesterol were comparable among the three different age-groups, indicating that these parameters in nephrotic patients are not influenced by age. This is in contrast to the findings reported by Damanik [12] , who found higher FIG. 1. Pattern of relapses at 12 months of follow-up for different age-groups. Patients with a disease onset between 1 and 3 years of age had significantly more relapses than those presenting at the age of 4-6 or 7-13 years ( 2 test).
percentage of hypertension, hematuria and azotemia in children older than 6 years. The male to female ratio was 2.6:1, which was similar to the finding reported by International Study of Kidney Disease in Children [13] . Approximately 70.7% of children had infections at the time of diagnosis. Conversely, Noer [8] observed lower incidence of infections (32.3%) in their cases at first presentation. We found a relatively higher proportion of infections, and this could be due to a primarily high incidence of infections in developing countries and to the fact that two-thirds of the patients stemmed from a rural region. Furthermore, these patients are also more prone to infections at the time of active disease owing to the loss of IgG and factor B in urine and T-cell dysfunction [3, 14] . Regarding pattern of relapses, 40.7% had no relapse and 59.3% had relapses (52% infrequent relapses, 7.3% frequent relapses and 0.6% steroid dependent) during the first 12 months after completion of treatment. Noer [8] reported 63.6% had relapsing nephrotic syndrome, including 50.5% infrequent relapsers and 13.3% frequent relapsers. Lewis et al. [15] and Kabuki et al. [16] reported the correlation between age at disease onset and frequency of relapse, with more frequent relapses in children younger than 4 years. We found precisely that children in the age-group of 1-3 years had significantly more relapses in comparison with other age-groups.
Among various descriptive factors, a high percentage of relapsers had an infection at the time of their first relapse. Relapsers had significantly higher mean number of infection than non-relapsers. They also had significantly high incidence of infection at the time of relapse than other time points. Thus, Various factors from the initial presentation were analyzed to calculate the hazard rates of first relapse. Age at the initial presentation and time to response were the only factors that significantly affected the risk of relapse.
assessing the infection rate at the time of relapse, which was almost more than four times, clearly indicates the role of infection in the occurrence of relapse. The occurrence of relapse is associated with infection, and this is thought to be due to increased interleukin-13 messenger RNA expression in response to infection. This interleukin may act on monocytes to produce vascular permeability factors involved in the pathogenesis of proteinuria in patients with relapse [17] . The relapsers received a higher total cumulative dose of steroid during the 12 months of follow-up period than non-relapsers because they required repeated courses of corticosteroid treatment to maintain remission and because the steroid dose was tapered over 12-18 months in frequent relapsers. The children receiving a relapsing course had lower median age, a delayed response and relatively shorter duration of the interval between steroid response and first relapse. Using discriminant function analysis, only two factors (younger age and time to response to the initial treatment) were found to predict the relapses significantly. The significance of time to response has been observed previously [1, 18] : longer the time required for remission, the greater was the possibility of becoming a relapser. Vivarelli et al. [18] found patients with non-relapsing and infrequent relapsing nephrotic syndrome had a median time to achieve remission of <7 days in contrast to patients with frequent relapsing and steroid dependence who had median time of response of >7 days. However, we analyzed it as different weeks' response after the start of treatment up to 8 weeks and derived a scoring system, which is a novel method and adds new insight into prediction of relapses in these patients.
In conclusion, this study confirms that children have a higher risk of relapse when they present with their first episode of idiopathic nephrotic syndrome between 1 and 3 years and need >4 weeks of prednisolone treatment to achieve remission. Furthermore, the occurrence of infections is more likely to precipitate relapses. We can identify such patients by putting the scores of age-group and time to response in equations derived. Thus, these factors can be used to predict the likelihood of relapses in patients with idiopathic nephrotic syndrome. This will help in preparing and guiding the families for the future course of the disease.
